Related Experiment Video
Updated: Aug 16, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis
Saisai Guo1, Xiaobo Lei2, Yan Chang3
1Department of Immunology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic has devastated global health. Identifying key host factors essential for SARS-CoV-2 RNA replication is expected to unravel cellular targets for the development of broad-spectrum antiviral drugs which have been quested for the preparedness of future viral outbreaks. Here, we have identified host proteins that associate with nonstructural protein 12 (nsp12), the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 using a mass spectrometry (MS)-based proteomic approach. Among the candidate factors, CDK2 (Cyclin-dependent kinase 2), a member of cyclin-dependent kinases, interacts with nsp12 and causes its phosphorylation at T20, thus facilitating the assembly of the RdRp complex consisting of nsp12, nsp7 and nsp8 and promoting efficient synthesis of viral RNA. The crucial role of CDK2 in viral RdRp function is further supported by our observation that CDK2 inhibitors potently impair viral RNA synthesis and SARS-CoV-2 infection. Taken together, we have discovered CDK2 as a key host factor of SARS-CoV-2 RdRp complex, thus serving a promising target for the development of SARS-CoV-2 RdRp inhibitors.
Insights
Researchers identified Cyclin-dependent kinase 2 (CDK2) as a crucial host factor for SARS-CoV-2 RNA replication. CDK2 inhibition effectively reduces viral RNA synthesis and infection, highlighting it as a promising target for new antiviral drugs.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- The COVID-19 pandemic underscores the urgent need for broad-spectrum antiviral therapies.
- Identifying host factors essential for SARS-CoV-2 replication is key to developing effective treatments and pandemic preparedness.
Purpose of the Study:
- To identify host proteins interacting with SARS-CoV-2 nonstructural protein 12 (nsp12), the RNA-dependent RNA polymerase (RdRp).
- To investigate the role of identified host factors in viral RNA synthesis and SARS-CoV-2 infection.
- To evaluate potential therapeutic targets for antiviral drug development.
Main Methods:
- Mass spectrometry (MS)-based proteomics was employed to identify host proteins associated with SARS-CoV-2 nsp12.
- The interaction between CDK2 and nsp12 was confirmed, and nsp12 phosphorylation at T20 by CDK2 was analyzed.
- The effect of CDK2 inhibitors on viral RNA synthesis and SARS-CoV-2 infection was assessed.
Main Results:
- Host protein Cyclin-dependent kinase 2 (CDK2) was identified as a nsp12-interacting protein.
- CDK2 facilitates the assembly of the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) complex (nsp12, nsp7, nsp8) by phosphorylating nsp12 at T20.
- CDK2 promotes efficient viral RNA synthesis and SARS-CoV-2 infection.
- CDK2 inhibitors significantly impair viral RNA synthesis and reduce SARS-CoV-2 infection.
Conclusions:
- CDK2 is a critical host factor for SARS-CoV-2 RNA replication and RdRp complex formation.
- CDK2 represents a promising therapeutic target for the development of novel SARS-CoV-2 antiviral drugs.
More Related Videos
Related Concept Videos
Viruses with RNA Genomes
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Inhibition of Cdk Activity
Viral Replication: Lytic Cycle
Positive Regulator Molecules
Leaky Scanning

